# Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"

> **NCT03214198** · — · COMPLETED · sponsor: **Takeda** · enrollment: 1304 (actual)

## Conditions studied

- A History of Gastric or Duodenal Ulcers

## Interventions

- **DRUG:** Vonoprazan

## Key facts

- **NCT ID:** NCT03214198
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 1304 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03214198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03214198, "Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03214198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*